Kronos Bio Valuation
| KRON Stock | USD 0.89 0.01 1.11% |
Today, the firm appears to be undervalued. Kronos Bio secures a last-minute Real Value of $2.82 per share. The latest price of the firm is $0.89. Our model forecasts the value of Kronos Bio from analyzing the firm fundamentals such as Return On Equity of -0.63, shares outstanding of 60.34 M, and Operating Margin of (6.49) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kronos Bio's valuation include:
Price Book 0.4903 | Enterprise Value -44.6 M | Enterprise Value Ebitda 0.8087 | Price Sales 6.4774 |
Undervalued
Today
Please note that Kronos Bio's price fluctuation is unstable at this time. Calculation of the real value of Kronos Bio is based on 3 months time horizon. Increasing Kronos Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kronos Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kronos Stock. However, Kronos Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.89 | Real 2.82 | Target 8.75 | Hype 0.89 | Naive 0.87 |
The intrinsic value of Kronos Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kronos Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kronos Bio helps investors to forecast how Kronos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kronos Bio more accurately as focusing exclusively on Kronos Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kronos Bio's intrinsic value based on its ongoing forecasts of Kronos Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kronos Bio's closest peers.
Kronos Bio Cash |
|
Kronos Valuation Trend
Knowing Kronos Bio's actual value is paramount for traders when making sound investment determinations. Using both Kronos Bio's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Kronos Bio Total Value Analysis
Kronos Bio is now estimated to have valuation of (44.57 M) with market capitalization of 54.49 M, debt of 28.27 M, and cash on hands of 267.89 M. The negative valuation of Kronos Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Kronos Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(44.57 M) | 54.49 M | 28.27 M | 267.89 M |
Kronos Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kronos Bio has an asset utilization ratio of 2.95 percent. This suggests that the Company is making $0.0295 for each dollar of assets. An increasing asset utilization means that Kronos Bio is more efficient with each dollar of assets it utilizes for everyday operations.Kronos Bio Ownership Allocation
Kronos Bio maintains a total of 60.34 Million outstanding shares. Kronos Bio holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kronos Bio Profitability Analysis
The company reported the previous year's revenue of 6.29 M. Net Loss for the year was (112.67 M) with profit before overhead, payroll, taxes, and interest of 0.About Kronos Bio Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Kronos Bio. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kronos Bio based exclusively on its fundamental and basic technical indicators. By analyzing Kronos Bio's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Kronos Bio's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kronos Bio. We calculate exposure to Kronos Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kronos Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.4 M | 1.4 M | |
| Pretax Profit Margin | (16.13) | (16.93) | |
| Operating Profit Margin | (17.44) | (18.31) | |
| Net Loss | (16.13) | (16.93) | |
| Gross Profit Margin | 0.20 | 0.18 |
Kronos Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 57.7 M |
Kronos Bio Current Valuation Indicators
Kronos Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kronos Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kronos Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kronos Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kronos Bio's worth.When determining whether Kronos Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kronos Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kronos Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kronos Bio Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Revenue Per Share 0.143 | Quarterly Revenue Growth 0.442 | Return On Assets (0.28) | Return On Equity (0.63) |
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.